and its subsidiary (the Company) hereby submits its reviewed consolidated financial statements for the second quarter ended 30th June 2018 which was duly approved by the Board of Directors. The Company

the Board of Directors’ Meeting No. 3/2018 which was held on Aug 9, 2018 passed a resolutions granting approval for the establishment of new subsidiary, details are as follow: Registration date : Sep 3

Public Company Limited (Mr. Deja Tulananda) Chairman of the Board of Executive Directors

above acquisition, calculated in accordance with the regulations of the Capital Market Supervisory Board and the Stock Exchange of Thailand, as prescribed by the regulations of the Stock Exchange of

Manager The Stock Exchange of Thailand The Board of Directors Meeting of O.C.C. Public Company Limited No. 5/2561 held on October 17, 2018 had resolved to approve the purchase of ordinary shares of Shop

statements for the third quarter ended 30th September 2018 which was duly approved by the Board of Directors. From the nine-month operations, the Company had a net loss of 47.58 million baht in which there is

the regulations of the Capital Market Supervisory Board and the Stock Exchange of Thailand, as prescribed by the regulations of the Stock Exchange of Thailand Re: Disclosure of Information and Other

Exchange of Thailand The Board of Directors Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.5/2019, held on November 13, 2019, has approved the financial statements of the

Capital Market Supervisory Board and the Stock Exchange of Thailand, as prescribed by the regulations of the Stock Exchange of Thailand Re: Disclosure of Information and Other Acts of Listed Companies

significantly higher than the estimate at the time of completion of acquisition, such increase being largely attributable to higher labor costs prevailing in the gulf coast region. The Board of Managers of CCP